Skip to main content
Caplight Logo









2A Biosciences

2A Biosciences

Private
Santa Monica, CaliforniaHealthcare & Life Scienceshttps://2abiosci.com

Last Round

Seed

Mar 15, 2023

Total Funding Raised

$5.25M

Company Overview

2A Biosciences operates in Healthcare & Life Sciences and is based in Santa Monica, California. Its latest recorded funding round was a Seed round in March 2023.

2A Biosciences is a biotechnology company developing proprietary non-hallucinogenic small molecules that activate serotonin 2A receptors to unlock regenerative and anti-inflammatory outcomes for degenerative and chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

2A Biosciences Comparables

Compare 2A Biosciences with similar companies based on industry and business-model similarity.

2A Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CaaMTech
45%
Mindstate Design Labs
42%
Freedom Biosciences
41%
Book a demo to see all comparables

For institutional investors. Book with your work email.

2A Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 15, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

2A Biosciences Investors

Notable investors and investment history

Book a demo to see all 10 investors

For institutional investors. Book with your work email.

2A Biosciences Filings

Explore SEC and related filing metadata, where available.

2A Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about 2A Biosciences's valuation, stock price, and market status.

Is 2A Biosciences a public or private company?

2A Biosciences is a private company.

What is the current stock price of 2A Biosciences?

2A Biosciences is a private company, so its shares have no public market price. Caplight tracks 2A Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is 2A Biosciences worth (valuation)?

Valuation information for 2A Biosciences is not publicly available.

Can I buy 2A Biosciences stock?

2A Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was 2A Biosciences's last funding round?

2A Biosciences's most recent funding round was Seed on March 15, 2023.

Who are the main investors in 2A Biosciences?

Key investors in 2A Biosciences include Gaingels, Lionheart Ventures, Capital Factory, Mystic Ventures, Calm Ventures.

Will 2A Biosciences IPO soon?

No public IPO plans have been announced for 2A Biosciences.

How can I track 2A Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in 2A Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersSanta Monica, California
Employee Range8
Year Founded2022
Last FundingMar 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?